RLAY: Relay Therapeutics, Inc. Stock

by  •  • Comments Off on RLAY: Relay Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 388.21
Enterprise Value ($M) 263.92
Book Value ($M) 777.79
Book Value / Share 4.59
Price / Book 0.50
NCAV ($M) 715.70
NCAV / Share 4.22
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.41
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.45

Liquidity (mrq)
Quick Ratio 15.95
Current Ratio 15.95

Balance Sheet (mrq) ($M)
Current Assets 809.20
Assets 871.30
Liabilities 93.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10.01
Operating Income -385.67
Net Income -337.71

Cash Flow Statement (mra) ($M)
Cash From Operations -249.11
Cash from Investing -41.08
Cash from Financing 270.15

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-20 13G Point72 Asset Management, L.P. 5.70
02-05 13G/A BlackRock, Inc. 8.80 53.28
11-14 13G/A Price T Rowe Associates Inc /md/ 3.30 -38.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 481,870 2,939,619 16.39
2025-04-03 477,240 2,496,581 19.12
2025-04-02 260,626 1,815,228 14.36
2025-04-01 616,338 2,189,760 28.15

(click for more detail)

Similar Companies
RANI – Rani Therapeutics Holdings, Inc. RAPT – RAPT Therapeutics, Inc.
RCKT – Rocket Pharmaceuticals, Inc. RNA – Avidity Biosciences, Inc.
RNAC – Cartesian Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io